Shortand medium-term results of knee replacement with modular eddoprothesis in maligant tumors of knee

The purpose - to evaluate the short- and medium-term results of treatment patients with knee tumors using modular endoprostheses GMRS (Stryker) and OSS (Biomet). Matherial and methods. The article presents the experience of use in clinical practice in patients with malignant tumors of the knee modular endoprosthesis (Global Modular Replacement System (Stryker) and Oncology Salvage System (Biomet). Also the results of analysis of these implant systems in primary total knee replacement in 63 patients. Results. Overall 5-year survival of patients of the study group was 87.3%, 5-year disease-free survival - 92.1%. Average follow-up was 4 years. Immediate and medium-term good and satisfactory results were achieved orthopedic in 51 (80.9%) patients; complications were noted in 5 (8.8%) cases